
Doctor Kari Stefansson
(Iceland)
Follow
Biography
Kári Stefánsson, M.D., Dr. Med. founded deCODE in August 1996. Dr. Stefánsson was previously a professor of Neurology, Neuropathology and Neuroscience at Harvard University and Director of Neuropathology at Beth Israel Hospital in Boston, Massachusetts. From 1983 to 1993, he held faculty positions in Neurology, Neuropathology and Neurosciences at the University of Chicago. Dr. Stefánsson received his M.D. and Dr. Med. from the University of Iceland and is board-certified in neurology and neuropathology in the United States. Dr. Stefansson is recognized as a leading figure in human genetics. He has shaped deCODE’s scientific approach and been actively engaged in leading its gene discovery work, serving as senior author on most of the company’s publications in major scientific journals.
Contributor content
Journal
Genetic variants associated with syncope implicate neural and autonomic processes
7 February 2023
Journal
Genetic insight into sick sinus syndrome
13 February 2021
Journal
Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease
23 July 2020
Journal
Rare <em>SCARB1</em> mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease
27 March 2018
Journal
A rare missense mutation in <em>MYH6</em> associates with non-syndromic coarctation of the aorta
24 March 2018

